Frazier Life Sciences Management
Venture Capital SEC-registered adviser
Legal name: Frazier Life Sciences Management, LP
AUM
$7.0B
Regulatory AUM
Private funds
8
Venture Capital 4 · Private Equity 3 · Hedge Fund 1
Private fund assets
$7.0B
Gross asset value
Employees
64
Last Form D raise
Mar 2025
Most recent fund filing
From SEC Form ADV filing (filed Mar 31, 2026). View on SEC
People(5)
Owners and executive officers named on the firm's SEC Form ADV.
A
D
J
J
P
Funds(6)
Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.
| Fund | Type | Gross assets | Raised (Form D) | Investors | Last Form D | Recency |
|---|---|---|---|---|---|---|
| Frazier Life Sciences XII, L.P. | Venture Capital | $1.4B | — | — | Mar 2025 | Cool |
| Frazier Life Sciences XI, L.P. | Venture Capital | $1.1B | $960.0M | 98 | Mar 2022 | Cold |
| Frazier Life Sciences Public Fund, L.P. | Hedge Fund | $2.9B | — | — | Dec 2019 | Cold |
| Frazier Life Sciences X, L.P. | Private Equity | $781.2M | — | — | Dec 2019 | Cold |
| Frazier Life Sciences IX, L.P. | Venture Capital | $596.5M | $418.9M | 55 | Nov 2017 | Cold |
| Frazier Life Sciences VIII, L.P. | Venture Capital | $260.2M | $262.0M | 46 | Oct 2015 | Cold |
Board seats
Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.
No board seats matched from SEC filings yet.
Regulatory identifiers
- CRD number
- 317522
- SEC file number
- 801-122904
Sources
- SEC Form ADV Oct 14, 2026